{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T12:26:18Z","timestamp":1791721578400,"version":"4.3.4"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T00:00:00Z","timestamp":1766102400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T00:00:00Z","timestamp":1769472000000},"content-version":"vor","delay-in-days":39,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82473405"],"award-info":[{"award-number":["82473405"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82303905"],"award-info":[{"award-number":["82303905"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82303911"],"award-info":[{"award-number":["82303911"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007129","name":"Natural Science Foundation of Shandong Province","doi-asserted-by":"publisher","award":["ZR2023QH046"],"award-info":[{"award-number":["ZR2023QH046"]}],"id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007129","name":"Natural Science Foundation of Shandong Province","doi-asserted-by":"publisher","award":["ZR2023QH196"],"award-info":[{"award-number":["ZR2023QH196"]}],"id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Although androgen receptor (AR)-targeted therapies, such as enzalutamide, initially improve outcomes of prostate cancer (PCa) patients, resistance inevitably develops, partly driven by prostate cancer stem-like cells (PCSCs). However, the molecular mechanisms linking the maintenance of PCSCs to enzalutamide resistance (ENZR) remain incompletely elucidated. Here, we implicate Ca\u00b2\u207a\/calmodulin-dependent protein kinase 1D (CAMK1D) in PCSC-mediated ENZR. CAMK1D was consistently upregulated in PCa with ENZR and contributed to ENZR by enhancing mitophagy in PCa cells both in vitro and in vivo. Mechanistically, CAMK1D promotes the expansion of PCSCs by enhancing mitophagy through activation of the AMP-activated protein kinase (AMPK)\/PINK1 signaling pathway, thereby facilitating cellular adaptation. We revealed that CAMK1D interacts with and phosphorylates AMPK at Thr172, which in turn activates PINK1 to modulate mitophagy, ultimately supporting the expansion of PCSCs under enzalutamide treatment. In a mouse orthotopic PCa model, targeting the CAMK1D\/AMPK pathway with the siCAM\/HLNP nanoformulation suppresses tumor growth by depleting the PCSCs population, achieving a synergistic effect with enzalutamide therapy. Our findings identify CAMK1D as a key regulator of ENZR that maintains stemness by orchestrating mitophagy, thereby establishing mitophagy as an important nexus between CAMK1D-mediated ENZR and AMPK-driven PCSC enrichment. Therapeutically, we developed a CAMK1D-targeted approach that potently reverses ENZR and improves treatment responses.<\/jats:p>","DOI":"10.1038\/s41419-025-08342-0","type":"journal-article","created":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T13:33:34Z","timestamp":1766151214000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["CAMK1D activates AMPK\/PINK1\/Parkin-dependent mitophagy to promote enzalutamide resistance in prostate cancer"],"prefix":"10.1038","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9304-0244","authenticated-orcid":false,"given":"Feifei","family":"Sun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Qu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuyu","family":"Mei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6044-9959","authenticated-orcid":false,"given":"Xianhao","family":"Shao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinpei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shijia","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenyao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muyi","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benkang","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6913-2410","authenticated-orcid":false,"given":"Lin","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4966-1398","authenticated-orcid":false,"given":"Bo","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,19]]},"reference":[{"key":"8342_CR1","first-page":"229","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74:229\u201363.","journal-title":"CA Cancer J Clin"},{"key":"8342_CR2","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1016\/j.stem.2024.06.003","volume":"31","author":"PE Saw","year":"2024","unstructured":"Saw PE, Liu Q, Wong PP, Song E. Cancer stem cell mimicry for immune evasion and therapeutic resistance. Cell Stem Cell. 2024;31:1101\u201312.","journal-title":"Cell Stem Cell"},{"key":"8342_CR3","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1016\/j.stem.2024.04.004","volume":"31","author":"JJ Loh","year":"2024","unstructured":"Loh JJ, Ma S. Hallmarks of cancer stemness. Cell Stem Cell. 2024;31:617\u201339.","journal-title":"Cell Stem Cell"},{"key":"8342_CR4","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1038\/35102167","volume":"414","author":"T Reya","year":"2001","unstructured":"Reya T, Morrison SJ, Clarke MF, Weissman IL. Stem cells, cancer, and cancer stem cells. Nature. 2001;414:105\u201311.","journal-title":"Nature"},{"key":"8342_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbcan.2023.188887","volume":"1878","author":"P Verma","year":"2023","unstructured":"Verma P, Shukla N, Kumari S, Ansari MS, Gautam NK, Patel GK. Cancer stem cell in prostate cancer progression, metastasis and therapy resistance. Biochim Biophys Acta Rev Cancer. 2023;1878:188887.","journal-title":"Biochim Biophys Acta Rev Cancer"},{"key":"8342_CR6","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.stem.2015.02.015","volume":"16","author":"V Plaks","year":"2015","unstructured":"Plaks V, Kong N, Werb Z. The cancer stem cell niche: how essential is the niche in regulating stemness of tumor cells?. Cell Stem Cell. 2015;16:225\u201338.","journal-title":"Cell Stem Cell"},{"key":"8342_CR7","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1158\/2326-6066.CIR-19-0608","volume":"8","author":"V Volpin","year":"2020","unstructured":"Volpin V, Michels T, Sorrentino A, Menevse AN, Knoll G, Ditz M, et al. CAMK1D triggers immune resistance of human tumor cells refractory to anti-PD-L1 treatment. Cancer Immunol Res. 2020;8:1163\u201379.","journal-title":"Cancer Immunol Res"},{"key":"8342_CR8","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1158\/2159-8290.CD-15-0854","volume":"6","author":"N Dimitrova","year":"2016","unstructured":"Dimitrova N, Gocheva V, Bhutkar A, Resnick R, Jong RM, Miller KM, et al. Stromal expression of miR-143\/145 promotes neoangiogenesis in lung cancer development. Cancer Discov. 2016;6:188\u2013201.","journal-title":"Cancer Discov"},{"key":"8342_CR9","doi-asserted-by":"publisher","first-page":"2442","DOI":"10.1182\/bloodadvances.2023011512","volume":"8","author":"CY Yao","year":"2024","unstructured":"Yao CY, Lin CC, Wang YH, Kao CJ, Tsai CH, Hou HA, et al. Kinome expression profiling improves risk stratification and therapeutic targeting in myelodysplastic syndromes. Blood Adv. 2024;8:2442\u201354.","journal-title":"Blood Adv"},{"key":"8342_CR10","doi-asserted-by":"publisher","first-page":"2097","DOI":"10.1084\/jem.20180421","volume":"215","author":"T Umemoto","year":"2018","unstructured":"Umemoto T, Hashimoto M, Matsumura T, Nakamura-Ishizu A, Suda T. Ca(2+)-mitochondria axis drives cell division in hematopoietic stem cells. J Exp Med. 2018;215:2097\u2013113.","journal-title":"J Exp Med"},{"key":"8342_CR11","first-page":"5219","volume":"8","author":"L Wang","year":"2016","unstructured":"Wang L, Lin Y, Meng H, Liu C, Xue J, Zhang Q, et al. Long non-coding RNA LOC283070 mediates the transition of LNCaP cells into androgen-independent cells possibly via CAMK1D. Am J Transl Res. 2016;8:5219\u201334.","journal-title":"Am J Transl Res"},{"key":"8342_CR12","doi-asserted-by":"publisher","first-page":"83913","DOI":"10.18632\/oncotarget.19996","volume":"8","author":"J Lawson","year":"2017","unstructured":"Lawson J, Dickman C, MacLellan S, Towle R, Jabalee J, Lam S, et al. Selective secretion of microRNAs from lung cancer cells via extracellular vesicles promotes CAMK1D-mediated tube formation in endothelial cells. Oncotarget. 2017;8:83913\u201324.","journal-title":"Oncotarget"},{"key":"8342_CR13","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1038\/nri.2017.145","volume":"18","author":"Y Huang","year":"2018","unstructured":"Huang Y, Kim BYS, Chan CK, Hahn SM, Weissman IL, Jiang W. Improving immune-vascular crosstalk for cancer immunotherapy. Nat Rev Immunol. 2018;18:195\u2013203.","journal-title":"Nat Rev Immunol"},{"key":"8342_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.neo.2024.101047","volume":"57","author":"J Hu","year":"2024","unstructured":"Hu J, Zhang J, Han B, Qu Y, Zhang Q, Yu Z, et al. PLXNA1 confers enzalutamide resistance in prostate cancer via AKT signaling pathway. Neoplasia. 2024;57:101047.","journal-title":"Neoplasia"},{"key":"8342_CR15","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1158\/2326-6066.CIR-20-0729","volume":"9","author":"H Ruan","year":"2021","unstructured":"Ruan H, Bao L, Tao Z, Chen K. Flightless I homolog reverses enzalutamide resistance through PD-L1-mediated immune evasion in prostate cancer. Cancer Immunol Res. 2021;9:838\u201352.","journal-title":"Cancer Immunol Res"},{"key":"8342_CR16","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-68187-9","volume":"10","author":"L Flynn","year":"2020","unstructured":"Flynn L, Barr MP, Baird AM, Smyth P, Casey OM, Blackshields G, et al. Prostate cancer-derived holoclones: a novel and effective model for evaluating cancer stemness. Sci Rep. 2020;10:11329.","journal-title":"Sci Rep"},{"key":"8342_CR17","doi-asserted-by":"publisher","first-page":"e2025932118","DOI":"10.1073\/pnas.2025932118","volume":"118","author":"JC Drake","year":"2021","unstructured":"Drake JC, Wilson RJ, Laker RC, Guan Y, Spaulding HR, Nichenko AS. et al. Mitochondria-localized AMPK responds to local energetics and contributes to exercise and energetic stress-induced mitophagy. Proc Natl Acad Sci USA. 2021;118:e2025932118","journal-title":"Proc Natl Acad Sci USA"},{"key":"8342_CR18","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1038\/nrm.2017.95","volume":"19","author":"S Herzig","year":"2018","unstructured":"Herzig S, Shaw RJ. AMPK: guardian of metabolism and mitochondrial homeostasis. Nat Rev Mol Cell Biol. 2018;19:121\u201335.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"8342_CR19","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1186\/s13045-018-0605-5","volume":"11","author":"C Chen","year":"2018","unstructured":"Chen C, Zhao S, Karnad A, Freeman JW. The biology and role of CD44 in cancer progression: therapeutic implications. J Hematol Oncol. 2018;11:64.","journal-title":"J Hematol Oncol"},{"key":"8342_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2025.107958","volume":"221","author":"W Cai","year":"2025","unstructured":"Cai W, Chen Y, Dai S, Zhao J, Chen L. Hyaluronic acid and its role in pancreatic cancer: Mechanisms of tumor progression, drug resistance, and therapeutic targeting. Pharmacol Res. 2025;221:107958.","journal-title":"Pharmacol Res"},{"key":"8342_CR21","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.neures.2006.09.013","volume":"57","author":"A Kamata","year":"2007","unstructured":"Kamata A, Sakagami H, Tokumitsu H, Owada Y, Fukunaga K, Kondo H. Spatiotemporal expression of four isoforms of Ca2+\/calmodulin-dependent protein kinase I in brain and its possible roles in hippocampal dendritic growth. Neurosci Res. 2007;57:86\u201397.","journal-title":"Neurosci Res"},{"key":"8342_CR22","doi-asserted-by":"publisher","first-page":"6784","DOI":"10.1021\/acs.jmedchem.9b01803","volume":"63","author":"C Fromont","year":"2020","unstructured":"Fromont C, Atzori A, Kaur D, Hashmi L, Greco G, Cabanillas A, et al. Discovery of highly selective inhibitors of calmodulin-dependent kinases that restore insulin sensitivity in the diet-induced obesity in vivo mouse model. J Med Chem. 2020;63:6784\u2013801.","journal-title":"J Med Chem"},{"key":"8342_CR23","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2024.1410102","volume":"12","author":"H Su","year":"2024","unstructured":"Su H, Huang L, Zhou J, Yang G. Prostate cancer stem cells and their targeted therapies. Front Cell Dev Biol. 2024;12:1410102.","journal-title":"Front Cell Dev Biol"},{"key":"8342_CR24","doi-asserted-by":"publisher","first-page":"2290","DOI":"10.3390\/cancers7040890","volume":"7","author":"D Ojo","year":"2015","unstructured":"Ojo D, Lin X, Wong N, Gu Y, Tang D. Prostate cancer stem-like cells contribute to the development of castration-resistant prostate cancer. Cancers. 2015;7:2290\u2013308.","journal-title":"Cancers"},{"key":"8342_CR25","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1186\/s13046-021-02147-7","volume":"40","author":"Y Lee","year":"2021","unstructured":"Lee Y, Yoon J, Ko D, Yu M, Lee S, Kim S. TMPRSS4 promotes cancer stem-like properties in prostate cancer cells through upregulation of SOX2 by SLUG and TWIST1. J Exp Clin Cancer Res. 2021;40:372.","journal-title":"J Exp Clin Cancer Res"},{"key":"8342_CR26","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.935715","volume":"12","author":"I Wolf","year":"2022","unstructured":"Wolf I, Gratzke C, Wolf P. Prostate cancer stem cells: clinical aspects and targeted therapies. Front Oncol. 2022;12:935715.","journal-title":"Front Oncol"},{"key":"8342_CR27","doi-asserted-by":"publisher","first-page":"459","DOI":"10.20517\/cdr.2022.07","volume":"5","author":"PP Kushwaha","year":"2022","unstructured":"Kushwaha PP, Verma S, Kumar S, Gupta S. Role of prostate cancer stem-like cells in the development of antiandrogen resistance. Cancer Drug Resist. 2022;5:459\u201371.","journal-title":"Cancer Drug Resist"},{"key":"8342_CR28","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/j.stem.2014.02.006","volume":"14","author":"A Kreso","year":"2014","unstructured":"Kreso A, Dick JE. Evolution of the cancer stem cell model. Cell Stem Cell. 2014;14:275\u201391.","journal-title":"Cell Stem Cell"},{"key":"8342_CR29","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms10798","volume":"7","author":"D Zhang","year":"2016","unstructured":"Zhang D, Park D, Zhong Y, Lu Y, Rycaj K, Gong S, et al. Stem cell and neurogenic gene-expression profiles link prostate basal cells to aggressive prostate cancer. Nat Commun. 2016;7:10798.","journal-title":"Nat Commun"},{"key":"8342_CR30","doi-asserted-by":"publisher","first-page":"7482","DOI":"10.3390\/ijms24087482","volume":"24","author":"Y Zhou","year":"2023","unstructured":"Zhou Y, Li T, Jia M, Dai R, Wang R. The molecular biology of prostate cancer stem cells: from the past to the future. Int J Mol Sci. 2023;24:7482","journal-title":"Int J Mol Sci"},{"key":"8342_CR31","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2023.1059441","volume":"13","author":"S Ramesh","year":"2023","unstructured":"Ramesh S, Selvakumar P, Ameer MY, Lian S, Abdullah Alzarooni AIM, Ojha S, et al. State-of-the-art therapeutic strategies for targeting cancer stem cells in prostate cancer. Front Oncol. 2023;13:1059441.","journal-title":"Front Oncol"},{"key":"8342_CR32","doi-asserted-by":"publisher","first-page":"434","DOI":"10.3390\/cancers11040434","volume":"11","author":"W Mei","year":"2019","unstructured":"Mei W, Lin X, Kapoor A, Gu Y, Zhao K, Tang D. The contributions of prostate cancer stem cells in prostate cancer initiation and metastasis. Cancers. 2019;11:434","journal-title":"Cancers"},{"key":"8342_CR33","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/j.molonc.2008.09.004","volume":"2","author":"A Bergamaschi","year":"2008","unstructured":"Bergamaschi A, Kim YH, Kwei KA, La Choi Y, Bocanegra M, Langerod A, et al. CAMK1D amplification implicated in epithelial-mesenchymal transition in basal-like breast cancer. Mol Oncol. 2008;2:327\u201339.","journal-title":"Mol Oncol"},{"key":"8342_CR34","doi-asserted-by":"publisher","first-page":"8862","DOI":"10.4238\/2014.October.31.1","volume":"13","author":"YP Yuan","year":"2014","unstructured":"Yuan YP, Shi YH, Gu WC. Analysis of protein-protein interaction network in chronic obstructive pulmonary disease. Genet Mol Res. 2014;13:8862\u20139.","journal-title":"Genet Mol Res"},{"key":"8342_CR35","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.cell.2009.12.007","volume":"140","author":"S Pece","year":"2010","unstructured":"Pece S, Tosoni D, Confalonieri S, Mazzarol G, Vecchi M, Ronzoni S, et al. Biological and molecular heterogeneity of breast cancers correlates with their cancer stem cell content. Cell. 2010;140:62\u201373.","journal-title":"Cell"},{"key":"8342_CR36","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1038\/s41422-022-00766-z","volume":"33","author":"XQ Xie","year":"2023","unstructured":"Xie XQ, Yang Y, Wang Q, Liu HF, Fang XY, Li CL, et al. Targeting ATAD3A-PINK1-mitophagy axis overcomes chemoimmunotherapy resistance by redirecting PD-L1 to mitochondria. Cell Res. 2023;33:215\u201328.","journal-title":"Cell Res"},{"key":"8342_CR37","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1016\/j.jhep.2020.12.031","volume":"74","author":"C Raggi","year":"2021","unstructured":"Raggi C, Taddei ML, Sacco E, Navari N, Correnti M, Piombanti B, et al. Mitochondrial oxidative metabolism contributes to a cancer stem cell phenotype in cholangiocarcinoma. J Hepatol. 2021;74:1373\u201385.","journal-title":"J Hepatol"},{"key":"8342_CR38","doi-asserted-by":"publisher","first-page":"3803","DOI":"10.1007\/s00018-021-03773-2","volume":"78","author":"DT Sessions","year":"2021","unstructured":"Sessions DT, Kashatus DF. Mitochondrial dynamics in cancer stem cells. Cell Mol Life Sci. 2021;78:3803\u201316.","journal-title":"Cell Mol Life Sci"},{"key":"8342_CR39","doi-asserted-by":"publisher","first-page":"1506","DOI":"10.1016\/j.stem.2022.09.002","volume":"29","author":"X Hong","year":"2022","unstructured":"Hong X, Isern J, Campanario S, Perdiguero E, Ramirez-Pardo I, Segales J, et al. Mitochondrial dynamics maintain muscle stem cell regenerative competence throughout adult life by regulating metabolism and mitophagy. Cell Stem Cell. 2022;29:1506\u20138.","journal-title":"Cell Stem Cell"},{"key":"8342_CR40","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.semcancer.2019.07.015","volume":"66","author":"DP Panigrahi","year":"2020","unstructured":"Panigrahi DP, Praharaj PP, Bhol CS, Mahapatra KK, Patra S, Behera BP, et al. The emerging, multifaceted role of mitophagy in cancer and cancer therapeutics. Semin Cancer Biol. 2020;66:45\u201358.","journal-title":"Semin Cancer Biol"},{"key":"8342_CR41","doi-asserted-by":"publisher","first-page":"1330","DOI":"10.18632\/aging.100976","volume":"8","author":"A Vazquez-Martin","year":"2016","unstructured":"Vazquez-Martin A, Van den Haute C, Cufi S, Corominas-Faja B, Cuyas E, Lopez-Bonet E, et al. Mitophagy-driven mitochondrial rejuvenation regulates stem cell fate. Aging. 2016;8:1330\u201352.","journal-title":"Aging"},{"key":"8342_CR42","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1038\/onc.2016.202","volume":"36","author":"LZ Xu","year":"2017","unstructured":"Xu LZ, Li SS, Zhou W, Kang ZJ, Zhang QX, Kamran M, et al. p62\/SQSTM1 enhances breast cancer stem-like properties by stabilizing MYC mRNA. Oncogene. 2017;36:304\u201317.","journal-title":"Oncogene"},{"key":"8342_CR43","doi-asserted-by":"publisher","first-page":"30","DOI":"10.3390\/cells11010030","volume":"11","author":"R Iorio","year":"2022","unstructured":"Iorio R, Celenza G, Petricca S. Mitophagy: molecular mechanisms, new concepts on Parkin activation and the emerging role of AMPK\/ULK1 axis. Cells. 2022;11:30","journal-title":"Cells"},{"key":"8342_CR44","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1007\/978-1-4939-7401-6_3","volume":"1692","author":"L Wang","year":"2018","unstructured":"Wang L, Zuo X, Xie K, Wei D. The role of CD44 and cancer stem cells. Methods Mol Biol. 2018;1692:31\u201342.","journal-title":"Methods Mol Biol"}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41419-025-08342-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-025-08342-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-025-08342-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T18:02:26Z","timestamp":1769536946000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41419-025-08342-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,19]]},"references-count":44,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["8342"],"URL":"https:\/\/doi.org\/10.1038\/s41419-025-08342-0","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,19]]},"assertion":[{"value":"6 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 November 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 December 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 December 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The study protocol was reviewed and approved by the Medical Research Ethics Committee of Qilu Hospital, Shandong University (Approval No. KYll-2022(ZM)-1359), and all procedures were conducted in accordance with the Declaration of Helsinki. All animal experiments were conducted in accordance with the Basel Declaration and approved by the Institutional Animal Care and Use Committee of Qilu Hospital, Shandong University (Document No. KYll-2022(ZM)-1359, date: January 1, 2024). Our animal experiments comply with regulations, ensuring that the size of solid tumors does not exceed 10% of the animal\u2019s body weight. We confirm that the maximum tumor volume has not been exceeded.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"All human tissue samples used in this study were obtained with informed consent from all participants.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"All authors agree with the content of the manuscript.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publish"}}],"article-number":"113"}}